アレルギー診断と治療の市場規模、シェア、成長分析、タイプ別、アレルゲンタイプ別、検査タイプ別、地域別 - 産業予測、2025～2032年

アレルギー診断と治療2023年の市場規模は306億9,000万米ドルで、2024年の333億9,000万米ドルから2032年には655億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.8%で成長する見通しです。

世界のアレルギー診断市場は、いくつかの重要な要因によって力強い成長が見込まれています。環境汚染の増加と医療保険へのアクセスの向上は、この拡大に不可欠な要因です。アレルギー疾患の有病率の増加は経済的に大きな影響をもたらし、アレルギー診断への投資の高まりと相まって、市場の成長をさらに促進しています。ライフスタイルの変化、特に不健康な加工食品の摂取や公害の増加は、この動向に大きな影響を与えています。さらに、食物アレルギーの急増は、しばしば食生活に対する意識の低さから生じており、アレルギー診断に対する需要の高まりを裏付けています。モバイルヘルス（mHealth）技術の統合と、革新的な治療と高度な診断戦略に関する継続的な研究は、アレルギー診断の展望を強化することを約束する技術的進歩を強化し、大きな市場機会を提示します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ分析

アレルギー診断と治療市場規模：タイプ別

• 市場概要
• 診断
  • 機器
  • 消耗品
  • サービス
• 治療薬
  • 抗ヒスタミン剤
  • 鬱血除去剤
  • コルチコステロイド
  • 肥満細胞安定剤
  • ロイコトリエン阻害剤
  • 鼻用抗コリン薬
  • 免疫調節剤
  • エピネフリン
  • 免疫療法

アレルギー診断と治療市場規模：アレルゲンタイプ別

• 市場概要
• 食品
  • 乳製品
  • 家禽製品
  • 木の実
  • ピーナッツ
  • 貝
  • 小麦
  • 大豆
  • その他の食物アレルゲン
• 吸入
• 薬
• その他のアレルゲン

アレルギー診断と治療市場規模：検査タイプ別

• 市場概要
• 生体内テスト
  • 皮膚プリックテスト
  • 皮内テスト
  • パッチテスト
• 体外試験

アレルギー診断と治療市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（US）
• Siemens Healthineers（Germany）
• Danaher（US）
• Omega Diagnostics Group PLC（UK）
• bioMerieux SA（France）
• Romer Labs Division Holding（Austria）
• EUROIMMUN Medizinische Labordiagnostika AG（Germany）
• HollisterStier Allergy（US）
• NEOGEN Corporation（US）
• Eurofins Scientific（Luxembourg）
• Minaris Medical America Inc.（US）
• HOB Biotech Group Corp. Ltd.（China）
• HYCOR Biomedical（US）
• R-Biopharm AG（Germany）
• AESKU.GROUP GmbH（Germany）
• ACON Laboratories Inc.（US）
• Lincoln Diagnostics Inc.（US）
• Astra Biotech GmbH（Germany）
• ERBA Group（UK）

結論と推奨事項

Allergy Diagnostics and Therapeutics Market size was valued at USD 30.69 Billion in 2023 and is poised to grow from USD 33.39 Billion in 2024 to USD 65.55 Billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global allergy diagnostics market is poised for robust growth driven by several key factors. Rising environmental pollution and greater healthcare insurance accessibility are vital contributors to this expansion. The increasing prevalence of allergic diseases, resulting in significant economic impact, combined with heightened investment in allergy diagnostics, further propel market growth. Lifestyle changes, particularly the intake of unhealthy processed foods and rising pollution, are major influencers on this trend. Additionally, the surge in food allergies, often stemming from poor dietary awareness, underscores the growing demand for allergy diagnostics. The integration of mobile health (mHealth) technologies and continuous research into innovative treatments and advanced diagnostic strategies present substantial market opportunities, reinforcing the technological advancements that promise to enhance the allergy diagnostics landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics And Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergy Diagnostics And Therapeutics Market Segmental Analysis

Global Allergy Diagnostics and Therapeutics Market is segmented by type, allergen type, test type and region. Based on type, the market is segmented into diagnostics and therapeutics. Based on allergen type, the market is segmented into food, inhaled, drug and other allergens. Based on test type, the market is segmented into in vivo test and in vitro test. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market is significantly driven by the rising prevalence of allergic diseases, especially among urban populations who face a greater risk due to their exposure to environmental pollutants. This heightened incidence not only affects public health but also imposes a substantial economic burden on healthcare systems, as more individuals seek diagnosis and treatment for various allergy-related conditions. As cities continue to grow and pollution levels rise, the demand for effective diagnostic and therapeutic solutions in allergy management will likely increase, further propelling the growth of this market. Consequently, addressing allergies has become a vital public health concern.

Restraints in the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market faces several constraints that may impede its growth trajectory. One significant challenge is the escalating costs associated with allergy diagnostic instruments, which can limit accessibility and affordability for healthcare providers and patients alike. Furthermore, the shortage of trained allergists may exacerbate these issues, hindering effective delivery of diagnostic services. This report delves into various aspects of the allergy diagnostics market, exploring recent developments, regulatory influences, and market dynamics, as well as identifying potential revenue opportunities and technological advancements. For further insights or assistance, please connect with Data Bridge Market Research for expert guidance.

Market Trends of the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market is witnessing a robust upward trend, driven by the rising prevalence of allergic diseases globally. With factors such as urbanization, environmental pollution, and shifting dietary patterns contributing to the surge in allergic conditions, healthcare systems are increasingly focused on effective diagnostic methods and innovative therapeutic solutions. Advancements in technology-ranging from enhanced testing kits to targeted biologics-are improving the accuracy and efficiency of allergy management. This rising awareness and demand for personalized treatment options are propelling market growth, making it essential for stakeholders to adapt to evolving patient needs and environmental challenges in this dynamic landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Allergy Diagnostics and Therapeutics Market Size by Type & CAGR (2024-2032)

• Market Overview
• Diagnostics
  • Instruments
  • Consumables
  • Services
• Therapeutics
  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anti-Cholinergic
  • Immuno-Modulators
  • Epinephrine
  • Immunotherapy

Global Allergy Diagnostics and Therapeutics Market Size by Allergen Type & CAGR (2024-2032)

• Market Overview
• Food
  • Dairy Products
  • Poultry Product
  • Tree Nuts
  • Peanuts
  • Shellfish
  • Wheat
  • Soys
  • Other Food Allergens
• Inhaled
• Drug
• Other Allergens

Global Allergy Diagnostics and Therapeutics Market Size by Test Type & CAGR (2024-2032)

• Market Overview
• In Vivo Test
  • Skin Prick Test
  • Intradermal Test
  • Patch Test
• In Vitro Test

Global Allergy Diagnostics and Therapeutics Market Size & CAGR (2024-2032)

• North America (Type, Allergen Type, Test Type)
  • US
  • Canada
• Europe (Type, Allergen Type, Test Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Allergen Type, Test Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Allergen Type, Test Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Allergen Type, Test Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Diagnostics Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romer Labs Division Holding (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROIMMUN Medizinische Labordiagnostika AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HollisterStier Allergy (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minaris Medical America Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOB Biotech Group Corp. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HYCOR Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AESKU.GROUP GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lincoln Diagnostics Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astra Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERBA Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations